Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial
Titel:
Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial
Auteur:
Gross-Goupil, M. Kwon, T.G. Eto, M. Ye, D. Miyake, H. Seo, S.I. Byun, S.-S. Lee, J.L. Master, V. Jin, J. DeBenedetto, R. Linke, R. Casey, M. Rosbrook, B. Lechuga, M. Valota, O. Grande, E. Quinn, D.I.